Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vividion Therapeutics, Inc.
QuantumLeap Healthcare Collaborative
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche
Eisai Inc.
Amgen